期刊文献+

盐酸吡格列酮与二甲双胍联合治疗2型糖尿病临床观察 被引量:2

下载PDF
导出
摘要 目的:探讨盐酸吡格列酮联合二甲双胍治疗2型糖尿病的临床疗效。方法:对笔者所在医院收治的42例2型糖尿病患者采用盐酸吡格列酮与二甲双胍联合进行治疗,作为观察组;另选取42例单独使用二甲双胍治疗的2型糖尿病患者作为对照组,对两组患者的临床疗效进行对比观察。结果:两组患者FBG、2 h BG、HbA1c三项指标治疗后与治疗前比较,均明显下降,差异有统计学意义(P<0.05);观察组与对照组比较,疗效更为显著,差异具有统计学意义(P<0.05)。两组患者均无严重不良反应发生。结论:盐酸吡格列酮与二甲双胍联合治疗2型糖尿病,能够通过不同机制改善胰岛素抵抗,降低血糖,疗效满意,是较为理想的用药方案。
作者 杨岩斌
机构地区 阳高县人民医院
出处 《中外医学研究》 2012年第30期23-24,共2页 CHINESE AND FOREIGN MEDICAL RESEARCH
  • 相关文献

参考文献5

二级参考文献23

  • 1Abbasi F, Chu JW, Mclaughlin T, et al. Effect of metformin treatment on multiple cardiovascular disease risk factors in patients with type 2 diabetes mellitus[J]. Metabolism,2004 53(2):159-164.
  • 2[1]Bretzel RG, Voigt K, Schatz H. The United Kingdom Prospective Diabetes Study(UKPDS) implications for the pharmacotherapy of type 2 diabetes mellitus. Exp Clin endocrinol Diabetes, 1998; 106:369~372.
  • 3[2]Haffner SM. Epdemiology of insulin resistance and its relation to coronary artery disease. American J Cardiology, 1999; 84:11 ~ 14.
  • 4[3]Lehmann JM, Moore LB, Smith-Oliver TA, et al. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferactor-activated receptor γ. J Biol Chem, 1995; 270:129~153.
  • 5[4]Hallakou S, Doare L, Foufelle F, et al. Pioglitazone induces in vivo adipocyte differentiation in the obese Zucker fa/fa rat. Diabetes,1997; 46:1393~ 1399.
  • 6[5]Kemnitz JW, Elson DF, Roecker EB, et al. Pioglitazone increases insulin sensitivity, reduces blood glucose, insulin, and lipid levels,and lowers blood pressure, in obese, insulin-resistant rhesus monkeys. Diabetes, 1994; 43:204~211.
  • 7[6]Chilcott J, Tappenden P, Jones ML, et al. A systematic review of the clinical effectiveness of pioglitazone in the treatment of type 2 diabetes mellitus. Clin Ther, 2001; 23:1792~1823.
  • 8[7]Rosenblatt S, Miskin B, Glazer NB, et al. The impact of pioglitazone on glycemic control and atherogenic dyslipidemia in patients with type 2 diabetes mellitus. Coron Artery Dis, 2001; 12:413~423.
  • 9[8]Hanefeld M, Belcher G. Safety profile of pioglitazone. Iht J Clin Pract, 2001, 121:27~31.
  • 10[9]Scheen AJ. Hepatotoxicity with thiazolidinediones: is it a class effect? Drug Saf, 2001; 24 873~888.

共引文献73

同被引文献13

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部